Search

Your search keyword '"Mallo M"' showing total 293 results

Search Constraints

Start Over You searched for: Author "Mallo M" Remove constraint Author: "Mallo M"
293 results on '"Mallo M"'

Search Results

151. Local indicators of climate change: The potential contribution of local knowledge to climate research.

152. TP53 and MDM2 single nucleotide polymorphisms influence survival in non-del(5q) myelodysplastic syndromes.

153. Correlation of myelodysplastic syndromes with i(17)(q10) and TP53 and SETBP1 mutations.

154. Validation of cytogenetic risk groups according to International Prognostic Scoring Systems by peripheral blood CD34+FISH: results from a German diagnostic study in comparison with an international control group.

155. Compartment-dependent activities of Wnt3a/β-catenin signaling during vertebrate axial extension.

156. Role of casein kinase 1A1 in the biology and targeted therapy of del(5q) MDS.

157. Long bone development requires a threshold of Hox function.

158. Evolving locomotion with Hoxc9.

159. Controlling Hox gene expression and activity to build the vertebrate axial skeleton.

160. Single nucleotide polymorphism array karyotyping: a diagnostic and prognostic tool in myelodysplastic syndromes with unsuccessful conventional cytogenetic testing.

161. 5q- syndrome and multiple myeloma diagnosed simultaneously and successful treated with lenalidomide.

162. The regulation of Hox gene expression during animal development.

163. Acquisition of cytogenetic abnormalities in patients with IPSS defined lower-risk myelodysplastic syndrome is associated with poor prognosis and transformation to acute myelogenous leukemia.

164. Response to lenalidomide in myelodysplastic syndromes with del(5q): influence of cytogenetics and mutations.

165. Role of a polymorphism in a Hox/Pax-responsive enhancer in the evolution of the vertebrate spine.

166. Switching axial progenitors from producing trunk to tail tissues in vertebrate embryos.

167. Application of FISH 7q in MDS patients without monosomy 7 or 7q deletion by conventional G-banding cytogenetics: does -7/7q- detection by FISH have prognostic value?

168. Regulatory role for a conserved motif adjacent to the homeodomain of Hox10 proteins.

169. New comprehensive cytogenetic scoring system for primary myelodysplastic syndromes (MDS) and oligoblastic acute myeloid leukemia after MDS derived from an international database merge.

170. Deletion of TET2 gene in an acute myeloid leukemia case with a t(4;15)(q24;q26) characterized by glass needle based chromosome microdissection and oligonucleotide array.

171. Concerted involvement of Cdx/Hox genes and Wnt signaling in morphogenesis of the caudal neural tube and cloacal derivatives from the posterior growth zone.

172. Clinical impact of the clone size in MDS cases with monosomy 7 or 7q deletion, trisomy 8, 20q deletion and loss of Y chromosome.

173. Cytogenetic risk stratification in chronic myelomonocytic leukemia.

174. Transient activation of meox1 is an early component of the gene regulatory network downstream of hoxa2.

175. Does monosomy 5 really exist in myelodysplastic syndromes and acute myeloid leukemia?

176. Hox genes and regional patterning of the vertebrate body plan.

177. Evidence for a myotomal Hox/Myf cascade governing nonautonomous control of rib specification within global vertebral domains.

178. Cdx and Hox genes differentially regulate posterior axial growth in mammalian embryos.

179. The road to the vertebral formula.

180. Gain of multiple copies of the CBFB gene: a new genetic aberration in a case of granulocytic sarcoma.

181. HOXB4's road map to stem cell expansion.

182. Bmp2 is required for migration but not for induction of neural crest cells in the mouse.

183. Could ATRA/Idarubicin treatment of acute promyelocytic leukemia induce the appearance of new clonal cytogenetic abnormalities in patients in complete remission?

184. And the segmentation clock keeps ticking.

186. Long-range upstream and downstream enhancers control distinct subsets of the complex spatiotemporal Sox9 expression pattern.

187. Controlled gene activation and inactivation in the mouse.

188. Hox genes specify vertebral types in the presomitic mesoderm.

189. A novel possible mechanism for the genesis of genomic duplications and its experimental test.

190. Tbx1 is required for proper neural crest migration and to stabilize spatial patterns during middle and inner ear development.

191. Hoxa2 downregulates Six2 in the neural crest-derived mesenchyme.

192. Mesenchymal patterning by Hoxa2 requires blocking Fgf-dependent activation of Ptx1.

193. Reversible gene inactivation in the mouse.

194. Formation of the outer and middle ear, molecular mechanisms.

195. Aortic arch and pharyngeal phenotype in the absence of BMP-dependent neural crest in the mouse.

196. Formation of the middle ear: recent progress on the developmental and molecular mechanisms.

197. Characterization of a recombinant monoclonal antibody by mass spectrometry combined with liquid chromatography.

198. Murine macrophages secrete interferon gamma upon combined stimulation with interleukin (IL)-12 and IL-18: A novel pathway of autocrine macrophage activation.

199. Embryological and genetic aspects of middle ear development.

200. Segmental identity can change independently in the hindbrain and rhombencephalic neural crest.

Catalog

Books, media, physical & digital resources